Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

v3.22.2.2
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2022
Basis of Presentation and Summary of Significant Accounting Policies (Tables) LineItems  
Schedule of reconciliation of the components of cash and restricted cash
    September 30,  
(in thousands)   2022
(unaudited)		     2021
(unaudited)		  
Cash and cash equivalents   $ 26,251     $ 10,786  
Restricted cash     125       125  
Restricted cash, non-current     621       207  
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows   $ 26,997     $ 11,118  

  
Schedule of liability deferred revenue
(in thousands)   Nine Months
Ended
September 30,
2022
(unaudited)		     Year Ended
December 31,
2021
(unaudited)		  
Balance, beginning of period   $ 6,238     $ 5,439  
Deferral of revenue     22,332       22,964  
Recognition of unearned revenue     (22,182 )     (22,165 )
Balance, end of period   $ 6,388     $ 6,238  

 
Schedule of diluted weighted-average shares of common stock outstanding
    September 30,
2022
(unaudited)		     September 30,
2021
(unaudited)		  
Common stock warrants     2,801,703       3,333,791  
Stock options     8,118,888       6,574,323  
      10,920,591       9,908,114